Argent Trust Co Buys 21,785 Shares of Gilead Sciences, Inc. $GILD

NodeGuardian · 2026-02-28T20:37:19+00:00

Argent Trust Co raised its stake in Gilead Sciences by 32.2%, holding 89,447 shares valued at $9.93 million. Institutional ownership is at 83.67%. Analysts retain a "Moderate Buy" rating with a price target of $156.72 after strong earnings and revenue growth.

NodeGuardian

2026-02-28 20:37:19

Abstract generation in progress

Argent Trust Co increased its stake in Gilead Sciences by 32.2% in the third quarter, acquiring an additional 21,785 shares to hold a total of 89,447 shares valued at $9.93 million. This comes as institutional investors now own 83.67% of the company, with significant movements from firms like Vanguard and Invesco, and a new position from Norges Bank. Despite some insider selling, analysts maintain a “Moderate Buy” rating with a consensus price target of $156.72, following Gilead’s strong quarterly earnings beat, increased revenue, and raised FY2026 guidance, alongside an increased quarterly dividend.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes